Charlotte's Web Holdings Inc
TSX:CWEB

Watchlist Manager
Charlotte's Web Holdings Inc Logo
Charlotte's Web Holdings Inc
TSX:CWEB
Watchlist
Price: 0.19 CAD 40.74% Market Closed
Market Cap: 30.2m CAD

Relative Value

The Relative Value of one CWEB stock under the Base Case scenario is 0.55 CAD. Compared to the current market price of 0.19 CAD, Charlotte's Web Holdings Inc is Undervalued by 66%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CWEB Relative Value
Base Case
0.55 CAD
Undervaluation 66%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
84
vs Industry
88
Median 3Y
0.5
Median 5Y
0.7
Industry
2.6
Forward
0.4
vs History
vs Industry
Median 3Y
-0.8
Median 5Y
-1
Industry
21.6
Forward
-1
vs History
vs Industry
Median 3Y
-1.6
Median 5Y
-4.5
Industry
16.5
vs History
vs Industry
Median 3Y
-1.1
Median 5Y
-3
Industry
22.5
vs History
19
vs Industry
74
Median 3Y
0.7
Median 5Y
0.9
Industry
2.3
vs History
39
vs Industry
80
Median 3Y
0.7
Median 5Y
0.8
Industry
2.9
Forward
1.1
vs History
44
vs Industry
77
Median 3Y
1.7
Median 5Y
2
Industry
5.5
vs History
vs Industry
58
Median 3Y
-1.4
Median 5Y
-1.7
Industry
13
Forward
-5.8
vs History
vs Industry
55
Median 3Y
-1
Median 5Y
-1.2
Industry
16.6
Forward
-3.6
vs History
vs Industry
56
Median 3Y
-2.4
Median 5Y
-4.1
Industry
15.8
vs History
vs Industry
42
Median 3Y
-2.1
Median 5Y
-4.1
Industry
19.1
vs History
36
vs Industry
78
Median 3Y
0.4
Median 5Y
0.5
Industry
1.9

Multiples Across Competitors

CWEB Competitors Multiples
Charlotte's Web Holdings Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Charlotte's Web Holdings Inc
TSX:CWEB
30.2m CAD 0.4 -1 -4.7 -3
US
Eli Lilly and Co
NYSE:LLY
971.9B USD 16.4 52.8 35.5 38
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
509.1B USD 5.5 20.3 16.6 21.5
CH
Roche Holding AG
SIX:ROG
252.3B CHF 4.1 26.8 11.5 13.4
UK
AstraZeneca PLC
LSE:AZN
208.5B GBP 4.8 29.7 108 158
CH
Novartis AG
SIX:NOVN
202.4B CHF 4.5 17.7 11.2 14.5
US
Merck & Co Inc
NYSE:MRK
249.5B USD 3.9 13.1 9.3 11.1
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK 4.5 13.7 9.6 11.2
IE
Endo International PLC
LSE:0Y5F
209B USD 90.1 -71.5 331.1 830.4
US
Pfizer Inc
NYSE:PFE
147B USD 2.3 15 7.6 10.4
P/E Multiple
Earnings Growth PEG
US
Charlotte's Web Holdings Inc
TSX:CWEB
Average P/E: 23.6
Negative Multiple: -1
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
52.8
53%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
20.3
29%
0.7
CH
Roche Holding AG
SIX:ROG
26.8
29%
0.9
UK
AstraZeneca PLC
LSE:AZN
29.7
38%
0.8
CH
Novartis AG
SIX:NOVN
17.7
17%
1
US
Merck & Co Inc
NYSE:MRK
13.1
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
13.7
4%
3.4
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -71.5 N/A N/A
US
Pfizer Inc
NYSE:PFE
15
29%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Charlotte's Web Holdings Inc
TSX:CWEB
Average EV/EBITDA: 438.7
Negative Multiple: -4.7
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
35.5
33%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.6
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.5
4%
2.9
UK
AstraZeneca PLC
LSE:AZN
108
10%
10.8
CH
Novartis AG
SIX:NOVN
11.2
6%
1.9
US
Merck & Co Inc
NYSE:MRK
9.3
6%
1.6
DK
Novo Nordisk A/S
CSE:NOVO B
9.6
2%
4.8
IE
E
Endo International PLC
LSE:0Y5F
331.1
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.6
1%
7.6
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Charlotte's Web Holdings Inc
TSX:CWEB
Average EV/EBIT: 1 881.1
Negative Multiple: -3
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
38
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21.5
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.4
5%
2.7
UK
AstraZeneca PLC
LSE:AZN
158
23%
6.9
CH
Novartis AG
SIX:NOVN
14.5
12%
1.2
US
Merck & Co Inc
NYSE:MRK
11.1
8%
1.4
DK
Novo Nordisk A/S
CSE:NOVO B
11.2
1%
11.2
IE
E
Endo International PLC
LSE:0Y5F
830.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.4
8%
1.3